Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Higher Versus Lower Blood Pressure Targets on Pulmonary Vascular Hemodynamics During Intensive Care After Out-of-Hospital Cardiac Arrest.

Acta anaesthesiologica Scandinavica·2026
Same author

Backrest Position and Outcome in Comatose Survivors of Out-of-Hospital Cardiac Arrest: Protocol for a Multi-Center Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) Trial.

Acta anaesthesiologica Scandinavica·2026
Same author

Prophylactic Olanzapine Versus Placebo in Comatose Survivors of Out-of-Hospital Cardiac Arrest: Protocol for a Multicenter Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) Trial.

Acta anaesthesiologica Scandinavica·2026
Same author

The Danish Out-of-Hospital Cardiac Arrest Trial: A Statistical Analysis Plan.

Acta anaesthesiologica Scandinavica·2026
Same author

Dexamethasone Versus Placebo in Comatose Survivors of Out-of-Hospital Cardiac Arrest: Study Protocol for a Multicenter Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest Trial (DANOHCA).

Acta anaesthesiologica Scandinavica·2026
Same author

Quantifying the efficacy-effectiveness gap in first line treatment of metastatic melanoma.

Journal of the National Cancer Institute·2026

Related Experiment Video

Updated: May 21, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Interleukin-6 and melanoma.

Lise Hoejberg1, Lars Bastholt, Henrik Schmidt

  • 1Department of Oncology, Odense University Hospital, Odense C, Denmark. ise.hoejberg@ouh.regionsyddanmark.dk

Melanoma Research
|June 21, 2012
PubMed
Summary
This summary is machine-generated.

Interleukin-6 (IL-6) is a cytokine involved in cancer. This review examines IL-6

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Related Experiment Videos

Last Updated: May 21, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Interleukin-6 (IL-6) is an immunomodulatory cytokine implicated in malignancy.
  • Elevated IL-6 serum levels correlate with poor prognosis in various cancers, including melanoma.
  • The precise role of IL-6 in melanoma progression remains unclear.

Purpose of the Study:

  • To review the current understanding of Interleukin-6 (IL-6) in melanoma.
  • To synthesize findings from cell culture, animal models, and clinical studies.

Main Methods:

  • Review of existing literature on IL-6 and melanoma.
  • Analysis of studies involving cell cultures.
  • Examination of data from mouse models.
  • Summarization of published clinical research.

Main Results:

  • IL-6 promotes tumor growth by inhibiting apoptosis and inducing angiogenesis.
  • IL-6 deregulation is observed in multiple cancer types.
  • Clinical studies indicate a correlation between increased IL-6 and worse melanoma prognosis.

Conclusions:

  • IL-6 is a significant factor in melanoma pathogenesis and progression.
  • Further research is needed to fully elucidate IL-6's biological functions in melanoma.
  • Understanding IL-6's role may lead to improved melanoma treatment strategies.